IM Cannabis Corp banner
I

IM Cannabis Corp
CNSX:IMCC

Watchlist Manager
IM Cannabis Corp
CNSX:IMCC
Watchlist
Price: 5.1 CAD -40% Market Closed
Market Cap: CA$9.7m

IM Cannabis Corp
Research & Development

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

IM Cannabis Corp
Research & Development Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Research & Development CAGR 3Y CAGR 5Y CAGR 10Y
I
IM Cannabis Corp
CNSX:IMCC
Research & Development
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bausch Health Companies Inc
TSX:BHC
Research & Development
-$629m
CAGR 3-Years
-6%
CAGR 5-Years
-7%
CAGR 10-Years
-7%
Canopy Growth Corp
TSX:WEED
Research & Development
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Cronos Group Inc
TSX:CRON
Research & Development
-$4.1m
CAGR 3-Years
38%
CAGR 5-Years
26%
CAGR 10-Years
N/A
Mind Medicine (MindMed) Inc
NASDAQ:MNMD
Research & Development
-$105.2m
CAGR 3-Years
-41%
CAGR 5-Years
-61%
CAGR 10-Years
-152%
K
Knight Therapeutics Inc
TSX:GUD
Research & Development
-CA$27.1m
CAGR 3-Years
-24%
CAGR 5-Years
-23%
CAGR 10-Years
-26%
No Stocks Found

IM Cannabis Corp
Glance View

Market Cap
9.7m CAD
Industry
Pharmaceuticals

IM Cannabis Corp. engages in the production and sale of medical cannabis products. The company is headquartered in Vancouver, British Columbia and currently employs 283 full-time employees. The firm operates in Israel through its commercial relationship with Focus Medical Herbs Ltd. (Focus Medical), where it cultivates, imports and distributes cannabis to medical patients, data and patient insights. The firm also operates medical cannabis retail pharmacies, online platforms, distribution centers and logistical hubs in Israel. The firm operates in Germany through Adjupharm GmbH (Adjupharm), where it is a certified medical cannabis producer and distributor with wholesale, narcotics handling, manufacturing, procurement, storage, and distribution licenses. The firm operates in Canada through Trichome JWC Acquisition Corp. d/b/a JWC and MYM Nutraceuticals Inc., where it cultivates and processes cannabis for the adult-use market at its Ontario and Nova Scotia facilities under the WAGNERS and Highland Grow brands.

IMCC Intrinsic Value
16.67 CAD
Undervaluation 69%
Intrinsic Value
Price
I

See Also

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett